Literature DB >> 14736419

Quantitation of dengue virus specific CD4+ T cells by intracellular cytokine staining.

Marlou M Mangada1, Francis A Ennis, Alan L Rothman.   

Abstract

We developed an intracellular cytokine staining assay to quantify dengue specific memory T cells elicited by a primary dengue virus (DEN) infection. Peripheral blood mononuclear cells (PBMC) of volunteers who received experimental live attenuated monovalent DEN vaccines were stimulated with glutaraldehyde-inactivated dengue-infected Vero cell culture lysates from all four DEN serotypes. CD4+ T cell frequencies to previously identified MHC class II peptides were equivalent to 40-70% of the responses using virus infected cell lysates in two donors. IFN-gamma responses to DEN were detected from 0.04% to 0.45% CD4+ T cells. The highest IFN-gamma response was elicited by antigens from the homologous serotype. We detected serotype-specific and -cross reactive CD4+ T cell cytokine responses from all donors. This assay is suitable for measuring DEN specific CD4+ T cells in human PBMC from large population studies where donor haplotype is unknown or highly variant.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736419     DOI: 10.1016/j.jim.2003.10.003

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection.

Authors:  Steven Hatch; Tim P Endy; Stephen Thomas; Anuja Mathew; James Potts; Pamela Pazoles; Daniel H Libraty; Robert Gibbons; Alan L Rothman
Journal:  J Infect Dis       Date:  2011-02-18       Impact factor: 5.226

2.  Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue.

Authors:  Nguyen Thi Phuong Dung; Huynh Thi Le Duyen; Nguyen Thi Van Thuy; Tran Van Ngoc; Nguyen Van Vinh Chau; Tran Tinh Hien; Sarah L Rowland-Jones; Tao Dong; Jeremy Farrar; Bridget Wills; Cameron P Simmons
Journal:  J Immunol       Date:  2010-05-12       Impact factor: 5.422

3.  Primary vaccination with low dose live dengue 1 virus generates a proinflammatory, multifunctional T cell response in humans.

Authors:  Janet C Lindow; Nathan Borochoff-Porte; Anna P Durbin; Stephen S Whitehead; Kelly A Fimlaid; Janice Y Bunn; Beth D Kirkpatrick
Journal:  PLoS Negl Trop Dis       Date:  2012-07-17

Review 4.  Dengue viruses - an overview.

Authors:  Anne Tuiskunen Bäck; Ake Lundkvist
Journal:  Infect Ecol Epidemiol       Date:  2013-08-30

5.  Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions.

Authors:  Philippe Moris; Kristen M Bauer; Jeffrey R Currier; Heather Friberg; Kenneth H Eckels; Ines O Esquilin; Robert V Gibbons; Bruce L Innis; Richard G Jarman; Sriluck Simasathien; Peifang Sun; Stephen J Thomas; Veerachai Watanaveeradej
Journal:  Hum Vaccin Immunother       Date:  2019-04-15       Impact factor: 3.452

Review 6.  The virus-immunity ecosystem.

Authors:  P C Doherty; S J Turner
Journal:  Arch Virol Suppl       Date:  2005

7.  Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T cell clone.

Authors:  Sarah Rowland-Jones; Tao Dong; Edward Moran; Cameron Simmons; Nguyen Vinh Chau; Kerstin Luhn; Bridget Wills; Nguyen Phuong Dung; Le Thi Thu Thao; Tran Tinh Hien; Jeremy Farrar
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

8.  Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.

Authors:  Daniel H Libraty; Kimberly M O'Neil; Lauren M Baker; Luz P Acosta; Remigio M Olveda
Journal:  Virology       Date:  2007-08-13       Impact factor: 3.616

9.  Computational prediction and identification of dengue virus-specific CD4(+) T-cell epitopes.

Authors:  Jin-Sheng Wen; Li-Fang Jiang; Jun-Mei Zhou; Hui-Jun Yan; Dan-Yun Fang
Journal:  Virus Res       Date:  2007-12-03       Impact factor: 3.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.